Healio Gastroenterology Current Issue

The following articles appeared in the print edition of Healio Gastroenterology.

Table of Contents

• Evidence of PPI Risks Weak, But Overuse Remains a Problem
• 10 Top Things an IBD Nurse Should Know
• At-home Gluten Test Launched in US, Canada
• Celgene Halts Mongersen Trials in Crohn’s Disease
• FDA Approves HBV Vaccine Heplisav-B for Adults
• FDA Clears Minimally Invasive, Robotically-assisted Surgical Device
• FDA Clears New Test to Aid in Identifying Hereditary Colon Cancer
• New Colonoscopy Dye Product Receives PDUFA Date
• Tenapanor Shows Better Results in Second Pivotal IBS-C Trial
• PPI Risk-Benefits: A Practical Approach to Patient Discussions Edward V. Loftus Jr., MD
• Recommendations Address ‘Public Health Concern’ of Hepatitis C in Pregnancy
• Genetic Testing Underused in Colon Cancer, Especially Young Patients
• Heavy Use of Prescription Opiates for IBD May Increase Mortality Rates
• IBD Patients on Thiopurines, Anti-TNFs Show ‘Small but Significant’ Lymphoma Risk
• Obesity Correlates With Discordance in Noninvasive Tests for Fibrosis
• Psoriasis, Inflammatory Diseases Increase Risk for Cirrhosis, Fatty Liver
• Whole Grain Diet Reduces Body Weight, Ineffective in Gut Microbiome
• Biologics Safer, More Cost-effective Than Corticosteroids Long-term in IBD
• Colon Cancer Screening Should Begin at Age 45, Per New Study
• Etrolizumab Shows Promise in Crohn’s Disease
• Integrated Specialty Pharmacy Improves Access to IBD Drugs
• IPAA Surgery Safe in Older IBD Patients
• Novel Blood Test Shows Promise for Parsing Celiac vs. Gluten Sensitivity
• Readmission Common After IPAA Surgery, Better Infection Control Needed
• ‘Tight Control’ of Inflammatory Biomarkers Improves Outcomes in Crohn’s Disease
• Bristol-Myers Squibb, Intercept Continue Support of NASH Study
• Cost, Fear of Side Effects Key Barriers to HCV Treatment
• The IBD Medical Home: A Holistic Approach to Specialty Care